(Q36279476)

13 August 2017

1 reference

title

How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events? (English)

1 reference

13 August 2017

Nick Freemantle

1

1 reference

PMC publication ID

1246089

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

331

1 reference

13 August 2017

7520

1 reference

13 August 2017

836-838

1 reference

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1246089

PubMed Central

reference URL

Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1246089

PubMed Central

reference URL

Carvedilol and the Food and Drug Administration (FDA) approval process: the FDA paradigm and reflections on hypothesis testing

30 September 2017

1 reference

https://pubmed.ncbi.nlm.nih.gov/16210286

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.331.7520.836

1 reference

13 August 2017

1 reference

PMC publication ID

1246089

13 August 2017

PubMed publication ID

16210286

1 reference

PMC publication ID

1246089